MediGene Set to Implement Strategic Turnaround
September 2009. For many months the TecDax-company is announcing re-focusing its business after the abrupt departure of Founder Peter Heinrich in April 2009. End of August shareholders at the Annual Meeting learned how this will by implemented during the months to come bringing MediGene to sustainable profitability. The Board is supporting the turnaround.
Includes a comparison of share prices with sector peersReading time: 2 min
Read Now: |
Other articles recommended
B2Bioworld offers you background information
Is that worth a dollar, or a million dollars?
Ed Torres, Managing Director of Lilly Ventures on the Fund’s approach and input to Eli Lilly’s business development